论文部分内容阅读
近年的研究[1,2]表明：可溶性白介素2受体（SIL-2R）在自身免疫性疾病、肿瘤患者的血清中显著地升高，且与病程、疗效及预后密切相关。葡萄胎患者血清中SIL-2R水平在国内尚未见报道，所以我们对此进行了探讨，现将其结果报道如下。对象和方法1对象32名葡萄胎患者均经临床明确诊
Recent studies [1, 2] show that soluble interleukin 2 receptor (SIL-2R) is significantly elevated in sera of patients with autoimmune diseases and cancer, and is closely related to the course of disease, efficacy and prognosis. The level of SIL-2R in the hydatidiform mole patients has not been reported in China, so we have discussed the results, the results are reported below. Subjects and methods 1 object 32 hydatidiform mole patients were clinically diagnosed